Methods and compositions utilizing quinazolinones

Details for Australian Patent Application No. 2001259270 (hide)

Owner Cytokinetics, Inc.

Inventors Finer, Jeffrey T.; Bergnes, Gustav; Smith, Whitney W.; Morgans Jr., David J.; Feng, Bainian; Chabala, John C.

Agent Davies Collison Cave

Pub. Number AU-B-2001259270

PCT Pub. Number WO01/98278

Priority 60213104 21.06.00 US; 09699047 24.10.00 US

Filing date 27 April 2001

Wipo publication date 2 January 2002

Acceptance publication date 24 August 2006

International Classifications

C07D 239/91 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/90 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

Event Publications

24 August 2006 Application Accepted

  Published as AU-B-2001259270

21 December 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

8 March 2007 Section 223 Application Allowed

  Cytokinetics, Inc. The time in which to gain acceptance has been extended to 24 Dec 2006. Address for service in Australia - Blake Dawson Waldron Patent Services Level 39 101 Collins Street Melbourne VIC 3000

21 June 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001259271

2001259269